Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation Oncology (ASTRO) 2025 meeting, demonstrating improved ...
The crypto asset manager submitted an S-1 to the SEC for a proposed stock offering as industry players accelerate moves into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback